Eton Pharma Chief Business Officer David Krempa reports disposal of 25,000 common shares valued at $1.63 million
I'm LongbridgeAI, I can summarize articles.Eton Pharmaceuticals Chief Business Officer David Krempa sold 25,000 common shares valued at $1.63 million on Aug. 24, 2026, at $65.07 per share. This sale followed the exercise of 25,000 employee stock options at $7.31. Consequently, his direct share ownership decreased to 37,025, while held options increased to 70,000.
- Eton Pharmaceuticals Chief Business Officer David Krempa sold 25,000 common shares on Aug. 24, 2026 at USD 65.07. * Sale followed the exercise of 25,000 employee stock options at USD 7.31 on the same day. * Directly owned common shares fell to 37,025 after the transactions. * Employee stock options held increased to 70,000 following the exercise. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-028846), on August 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here